je.st
news
Merck melanoma drug shrinks tumors in 38 percent of patients
2013-06-02 18:54:47| Biotech - Topix.net
A Merck & Co drug designed to unmask tumor cells and mobilize the immune system into fighting cancer helped shrink tumors in 38 percent of patients with advanced melanoma in an early-stage study, U.S. researchers said on Sunday.
Tags: of
drug
percent
patients
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||